B-POCKET TRANSPLANT FROM HLA-A2 INTO B27 CHANGES REQUIREMENT FOR P-2 ANCHOR RESIDUE IN PEPTIDE PRESENTATION

B-POCKET TRANSPLANT FROM HLA-A2 INTO B27 CHANGES REQUIREMENT FOR P-2 ANCHOR RESIDUE IN PEPTIDE PRESENTATION

Bibliografski detalji
Glavni autori:	Colbert, R, Rowlandjones, S, Mcmichael, A, Frelinger, J
Format:	Journal article
Izdano:	1993

Slični predmeti

Allele-specific B pocket transplant in class I major histocompatibility complex protein changes requirement for anchor residue at P2 of peptide.
od: Colbert, R, i dr.
Izdano: (1993)

Allele-specific B pocket transplant in class I major histocompatibility complex protein changes requirement for anchor residue at P2 of peptide.
od: Colbert, R, i dr.
Izdano: (1993)

DIFFERENCES IN PEPTIDE PRESENTATION BETWEEN B27 SUBTYPES - THE IMPORTANCE OF THE P1 SIDE-CHAIN IN MAINTAINING HIGH-AFFINITY PEPTIDE BINDING TO B-ASTERISK-2703
od: Colbert, R, i dr.
Izdano: (1994)

Structural homologies between two HLA B27-restricted peptides suggest residues important for interaction with HLA B27.
od: Huet, S, i dr.
Izdano: (1990)

Differences in peptide presentation between B27 subtypes: the importance of the P1 side chain in maintaining high affinity peptide binding to B*2703.
od: Colbert, R, i dr.
Izdano: (1994)

Naturally occurring A pocket polymorphism in HLA-B*2703 increases the dependence on an accessory anchor residue at P1 for optimal binding of nonamer peptides.
od: Griffin, T, i dr.
Izdano: (1997)

An HLA-B35-restricted epitope modified at an anchor residue results in an antagonist peptide.
od: Dong, T, i dr.
Izdano: (1996)

Significance of the six peptide-binding pockets of HLA-A2.1 in influenza A matrix peptide-specific cytotoxic T-lymphocyte reactivity.
od: Matsui, M, i dr.
Izdano: (1994)

Identification of T cell receptor recognition residues for a viral peptide presented by HLA B27.
od: Bowness, P, i dr.
Izdano: (1994)

The solvent-inaccessible Cys67 residue of HLA-B27 contributes to T cell recognition of HLA-B27/peptide complexes.
od: Appel, H, i dr.
Izdano: (2004)

IDENTIFICATION OF T-CELL RECEPTOR RECOGNITION RESIDUES FOR AN INFLUENZA-VIRUS NONAMER PEPTIDE EPITOPE PRESENTED BY HLA B27
od: Bowness, P, i dr.
Izdano: (1995)

Interaction of HLA-B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA-B27 heterotrimers, is independent of the sequence of bound peptide.
od: Kollnberger, S, i dr.
Izdano: (2007)

Misfolding of HLA-B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondyloarthropathies.
od: Mear, J, i dr.
Izdano: (1999)

HLA class I typing by PCR: HLA-B27 and an African B27 subtype.
od: Hill, A, i dr.
Izdano: (1991)

The role of HLA-B27 in spondyloarthritis.
od: Allen, R, i dr.
Izdano: (1999)

HLA-B27-RESTRICTED PEPTIDE PRESENTATION TO CYTOTOXIC T-CELLS IN REACTIVE ARTHRITIS
od: Bowness, P, i dr.
Izdano: (1995)

Expression of aberrant HLA-B27 molecules is dependent on B27 dosage and peptide supply.
od: McHugh, K, i dr.
Izdano: (2014)

ERAP2 is associated with ankylosing spondylitis in HLA-B27-positive and HLA-B27-negative patients.
od: Robinson, P, i dr.
Izdano: (2015)

HLA-B27
od: Bowness, P
Izdano: (2015)

HOMOCYSTEINE AND HLA B27-ASSOCIATED ARTHROPATHIES
od: Gao, X, i dr.
Izdano: (1995)

HLA-B27 transgenic rodents express cell surface HLA-B27 heavy chain homodimers and multimers.
od: Bowness, P, i dr.
Izdano: (2003)

Functional characterisation of HLA-B27 in autoimmunity
od: Kollnberger, S, i dr.
Izdano: (2001)

Identification of HLA-B27-restricted peptides from the Chlamydia trachomatis proteome with possible relevance to HLA-B27-associated diseases.
od: Kuon, W, i dr.
Izdano: (2001)

Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptides
od: Yang, X, i dr.
Izdano: (2022)

Residue Cys-67 of HLA-B27 contributes to antigen presentation and T cell recognition of HLA-B27 restricted T cell epitopes.
od: Appel, H, i dr.
Izdano: (2004)

IMMUNOGENIC HIV VARIANT PEPTIDES THAT BIND TO HLA-B8 BUT FAIL TO STIMULATE CYTOTOXIC T-LYMPHOCYTE RESPONSES
od: Mcadam, S, i dr.
Izdano: (1995)

HLA-B27: natural function and pathogenic role in spondyloarthritis.
od: McMichael, A, i dr.
Izdano: (2002)

A cluster of mutations in HLA-A2 alpha 2 helix abolishes peptide recognition by T cells.
od: Moots, R, i dr.
Izdano: (1991)

Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility.
od: Evans, D, i dr.
Izdano: (2011)

Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility
od: Evans, D, i dr.
Izdano: (2011)

The KIRs of HLA-B27: the role of HLA-B27 KIR interactions in infection and spondyloarthritis
od: Wong-Baeza, I, i dr.
Izdano: (2011)

Identification and characterisation of cell surface HLA-B27 homodimers
od: Bird, L, i dr.
Izdano: (2002)

Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide binding
od: Walters, L, i dr.
Izdano: (2018)

The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9.
od: Braud, V, i dr.
Izdano: (1997)

Importance of a conserved TCR J alpha-encoded tyrosine for T cell recognition of an HLA B27/peptide complex.
od: Bowness, P, i dr.
Izdano: (1998)

Genotyping HLA-B27 in spondyloarthropathies.
od: Brown, M, i dr.
Izdano: (1998)

HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors.
od: Kollnberger, S, i dr.
Izdano: (2004)

Genetic modulation of antigen presentation by HLA-B27 molecules.
od: Pazmany, L, i dr.
Izdano: (1992)

Analysis of mutant HLA-A2 molecules. Differential effects on peptide binding and CTL recognition.
od: Tussey, L, i dr.
Izdano: (1994)

Evidence of widespread binding of HLA class I molecules to peptides.
od: Frelinger, J, i dr.
Izdano: (1990)